Cullinan Therapeutics Inc.

This early-stage study is testing the safety of an experimental drug called CLN-978 in people with moderate to severe lupus. The drug is given as an injection under the skin. Researchers will enroll 24 participants whose lupus remains active despite trying at least two standard t…

This is the first study in people of an experimental drug called CLN-049 for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the drug move…

This early-stage study is testing the safety and side effects of an experimental drug called CLN-978 in people with active, moderate to severe Sjogren's disease. The drug is given as an injection under the skin. Researchers will enroll 36 participants to monitor for any adverse r…